Canine Orthopedics Market - Global Industry Size, Share, Trends, Opportunity, and Forecast, 2021-2031

The Global Canine Orthopedics Market is projected to expand from USD 262.53 Million in 2025 to USD 434.74 Million by 2031, achieving a compound annual growth rate (CAGR) of 8.77%. This sector encompasses the production and supply of medical implants, instruments, and supportive devices specifically engineered to manage musculoskeletal injuries and degenerative diseases in dogs. A major force propelling this industry is the growing trend of pet humanization alongside increasing pet ownership, which encourages owners to pursue sophisticated medical treatments for conditions like osteoarthritis and cruciate ligament ruptures. Highlighting this expanding patient base, the American Veterinary Medical Association estimated the United States dog population at 89.7 million in 2024, a figure that directly underpins the demand for specialized veterinary orthopedic products and services.

Despite these favorable trends, the market faces a substantial obstacle regarding the significant expense of complex orthopedic surgeries. Procedures such as total hip replacements and fracture repairs necessitate costly materials and the expertise of highly skilled veterinary specialists, creating a heavy financial load for pet owners. This affordability barrier frequently restricts access to premium veterinary care for uninsured pets and hampers market penetration in developing areas where disposable income is lower and veterinary healthcare infrastructure is not yet fully established.

Market Drivers

The escalating prevalence of canine musculoskeletal disorders and obesity serves as a primary engine for market expansion, generating consistent demand for orthopedic interventions. Excess body weight in dogs markedly hastens joint deterioration, resulting in higher rates of osteoarthritis and cruciate ligament injuries that necessitate surgical repair or long-term management via implants. The correlation between weight and orthopedic health is increasingly apparent in clinical statistics; according to the Association for Pet Obesity Prevention's '2024 Pet Obesity & Nutrition Opinion Survey' released in April 2025, 35% of dog owners identified their pets as overweight or having obesity, a significant rise from 17% the previous year. This increase in the at-risk population drives the need for comprehensive orthopedic solutions, ranging from diagnostic tools to advanced surgical implants, as veterinarians manage the physical consequences of weight-related comorbidities.

In parallel, the growing uptake of pet health insurance policies is alleviating the financial hurdles linked to expensive orthopedic procedures, thereby widening patient access to high-quality care. As coverage becomes more prevalent, owners are more inclined to authorize costly treatments like total hip replacements or fracture repairs that might otherwise be financially out of reach. According to the North American Pet Health Insurance Association's '2025 State of the Industry Report' from April 2025, total pet insurance premium volume in the United States hit roughly $4.7 billion by the end of 2024. This financial safety net is crucial given the escalating costs of veterinary medicine, with Synchrony estimating in 2025 that the lifetime cost of dog care has increased to between $22,125 and $60,602, making the insurance sector a key facilitator in converting potential demand into realized surgical revenue.

Market Challenges

The significant expense attached to complex orthopedic surgeries acts as a major impediment to the growth of the Global Canine Orthopedics Market. Interventions such as total hip replacements and cruciate ligament repairs require high-cost medical-grade implants and the skills of specialized veterinary surgeons. As a result, the cost of these procedures frequently surpasses the disposable income of many pet owners, compelling them to choose conservative, non-surgical management or, in extreme situations, economic euthanasia. This economic limitation directly decreases the volume of implants and instruments used, thereby hindering market revenue potential and restricting the uptake of advanced technologies.

Additionally, the market depends heavily on out-of-pocket payments because pet health insurance remains relatively uncommon. The absence of financial safety nets worsens the affordability gap, especially when owners confront sudden, substantial medical bills. According to the North American Pet Health Insurance Association, the total number of insured pets in North America reached 7.03 million in 2024. This statistic suggests that the vast majority of the pet population is still uninsured, leaving most owners solely accountable for the heavy financial load of premium orthopedic care and significantly limiting the addressable market for surgical solutions.

Market Trends

The integration of Regenerative Medicine Therapies with Orthopedic Procedures is transitioning the market's focus from simple symptom management to biological restoration. Veterinary surgeons are increasingly combining stem cell therapies and platelet-rich plasma with surgical interventions to hasten tissue healing and slow the progression of osteoarthritis. This method is becoming commercially viable as biotechnology companies attract significant investment to create standardized, off-the-shelf biological products. For instance, Gallant Therapeutics announced in a June 2025 press release, 'Gallant Closes $18 Million Series B to Bring Ready-to-Use Stem Cell Therapies for Pets to Market,' that it secured $18 million to further the conditional FDA approval of its allogeneic stem cell pipeline, signaling a shift toward scalable therapeutics that treat the root causes of joint degeneration rather than just masking pain.

Concurrently, the expansion of Specialized Post-Operative Physical Rehabilitation Modalities is solidifying structured recovery protocols as a vital element of orthopedic care. The veterinary community increasingly acknowledges that surgical results are vastly improved when accompanied by professional rehabilitation, fueling demand for sports medicine specialists and specific recovery programs. This development is bolstered by growing funding for clinical research aimed at perfecting rehabilitation techniques for canine athletes. As reported by the American Kennel Club Canine Health Foundation in its August 2025 '2024 Impact Report,' the organization strategically invested $3.2 million across 42 research grants, including specific support for sports medicine and rehabilitation residency programs, which is essential for validating evidence-based strategies to ensure complex orthopedic repairs lead to optimal long-term functional mobility.

Key Players Profiled in the Canine Orthopedics Market

• B. Braun SE
• Movora
• Steris PLC
• Johnson & Johnson Services, Inc.
• Cencora, Inc.
• Arthrex, Inc.
• Orthomed (UK) Ltd.
• Veterinary Instrumentation Ltd.
• Fusion Implants
• Narang Medical Limited

Report Scope

In this report, the Global Canine Orthopedics Market has been segmented into the following categories:

Canine Orthopedics Market, by Product:

• Implants
• Instruments

Canine Orthopedics Market, by Application:

• TPLO
• TTA
• Joint Replacement
• Trauma
• Others

Canine Orthopedics Market, by End-use:

• Hospitals & Clinics
• Others

Canine Orthopedics Market, by Region:

• North America
• Europe
• Asia-Pacific
• South America
• Middle East & Africa

Competitive Landscape

Company Profiles: Detailed analysis of the major companies present in the Global Canine Orthopedics Market.

Available Customization

The analyst offers customization according to your specific needs. The following customization options are available for the report:

• Detailed analysis and profiling of additional market players (up to five).

This product will be delivered within 1-3 business days.